BVF Partners OS Ltd., Insider at Nivalis Therapeutics, Inc. (NVLS), bought 17,806 shares at $2.25 ($40K) on 2017-06-20, disclosed to the SEC on 2017-06-22.
Open-market purchase of $40k NVLS by Insider. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.25 | 1,715 | $4K | 9.6% |
| 2 | $2.25 | 6,359 | $14K | 35.7% |
| 3 | $2.25 | 9,732 | $22K | 54.7% |
| Total | $2.25 avg | 17,806 | $40K | 100% |
| Filing → |
| XOMA | BUY | 2020-09-23 | $1.8M | — | Filing → |
| IDYA | BUY | 2020-06-22 | $3.4M | — | Filing → |
| FPRX | BUY | 2019-12-26 | $4.2M | — | Filing → |